ILMN

7 Stocks to Buy and Hold for the Next 20 Years

By Larry Ramer, InvestorPlace Contributor
When choosing stocks to buy and hold for the next 20 years, pick companies with strong comparative advantages in durable sectors. 

Ranking 7 Top Tech Stocks to Buy From Biggest to Smallest

By Larry Ramer, InvestorPlace Contributor
Although "Big Tech" is currently struggling, but there are still many good top tech stocks to buy at this point.

3 Biotech Stocks to Sell in October

By Muslim Farooque, InvestorPlace Contributor
These biotech stocks to sell are at a cross roads with their businesses with few growth catalysts ahead amid this turbulent market.

The 3 Best Healthcare Stocks to Buy Now

By Larry Ramer, InvestorPlace Contributor
Investors are less worried about the regulation of the U.S. healthcare sector, making this a good time to buy the best healthcare stocks. 

Illumina (ILMN) Stock Rises After Its Win Against the FTC

By Josh Enomoto, InvestorPlace Contributor
Illumina just secured a major legal win against the FTC regarding an acquisition, initially sparking a boost in ILMN stock.

Why Is Illumina (ILMN) Stock Plunging 10% Today?

By Shrey Dua, InvestorPlace Assistant News Writer
California-based gene sequencer Illumina is well in the red today after a brutal earnings miss. ILMN stock is down 10% on weak results.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer
Good morning! We're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday!

7 Wildly Oversold S&P 500 Stocks to Buy Now

By Ian Bezek, InvestorPlace Contributor
These seven S&P 500 stocks to buy have crashed amid 2022's market turmoil and are now set for a swift rebound.

3 Biotech Stocks to Sell Now

By Tyler Craig, Tales of a Technician
These biotech stocks remain vulnerable to more downside. Their charts remain broken and resistance looms ominously overhead.

7 Beaten-Down S&P 500 Stocks to Buy Before They Rebound

By Larry Ramer, InvestorPlace Contributor
With the market becoming more convinced that a "soft landing" is in the cards, there are many good, beaten-down S&P 500 stocks to buy. 

Forget About the Genomic Revolution, the Proteomic Revolution Is Coming

By Luke Lango, InvestorPlace Senior Investment Analyst
Thanks to one small protein sequencing startup, we're entering a new era of proteomics via NGPS technologies that will enable massively parallel protein sequencing.

Forget About the Genomic Revolution, the Proteomic Revolution Is Coming

By Luke Lango, InvestorPlace Senior Investment Analyst
Thanks to one small protein sequencing startup, we're entering a new era of proteomics via NGPS technologies that will enable massively parallel protein sequencing.

7 Great Growth Stocks to Buy Now to Build Your Portfolio

By Tezcan Gecgil, InvestorPlace Contributor
These growth stocks could boost growth portfolios in the coming quarters

Illumina Stock Will Be Unstoppable Once the Grail Acquisition Gets Approved

By Larry Ramer, InvestorPlace Contributor
Illumina will likely be allowed to buy Grail. But even without that deal, ILMN stock is very attractive, given the company's strong growth drivers.

5 Healthcare Stocks to Buy for Their Game-Changing Potential

By Larry Ramer, InvestorPlace Contributor
These healthcare stocks are at the forefront of huge trends, including precision medicine and advances in diagnosis technologies.

7 Beaten-Down Stocks to Buy Right Now for a June Rebound

By Tezcan Gecgil, InvestorPlace Contributor
Are you looking for stocks that have been beaten up in recent weeks? Here are seven stocks to buy right now at the start of the summer.

7 Healthcare Stocks to Buy and Hold for the Long Term

By Faisal Humayun, InvestorPlace Contributor
These steady, strong healthcare stocks are great picks for investors to buy and hold onto for at least the next five years.

7 Healthcare Stocks to Buy With the Sector Under Scrutiny

By Tom Taulli, InvestorPlace Contributor
True, there are political risks in the industry. But there are also lots of growth opportunities for investors in healthcare stocks.

7 Unhealthy Biotech Stocks To Sell Before They Sicken Your Portfolio

By Louis Navellier and the InvestorPlace Research Staff
It’s a good time to separate the weak from the strong.
Load More